COVID-19/SARS-COV-2 / RESEARCH LETTER
Continuing cancer care delivery during the peak of COVID-19 in the Bronx, New York: experience from a public teaching hospital
| 1 | Division of Hematology-Oncology, New York City Health and Hospital Corporation/
Lincoln Medical and Mental Health Center, the Bronx, New York, USA |
| 2 | Division of Hematology-Oncology, Westchester Medical Center, New York Medical
College, Valhalla, New York, USA |
| 3 | Department of Cardiology, Westchester Medical Center, New York Medical College,
Valhalla, New York, USA |
| 4 | Department of Internal Medicine, New York City Health and Hospital Corporation/
Lincoln Medical and Mental Health Center, the Bronx, New York, USA |
CORRESPONDING AUTHOR
Surabhi Pathak
New York Health and Hospital Corporation/Lincoln, 234 East 149th Street, 10451, Bronx, United States
New York Health and Hospital Corporation/Lincoln, 234 East 149th Street, 10451, Bronx, United States
Submission date: 2021-04-19
Acceptance date: 2021-04-30
Publication date: 2021-04-30
Arch Med Sci 2021;17(4):1109–1113
KEYWORDS
TOPICS
ABSTRACT
Introduction:
We report our experience with cancer care delivery during the peak of COVID-19 pandemic in New York City.
Material and methods:
Retrospective analysis of the patients treated from the 1st of March, 2020 to the 8th of May, 2020.
Results:
Team huddles, infection screening and patient selection strategies were implemented. 170 patients were treated in 576 visits. Six developed severe COVID-19 requiring hospitalization, two died. Their median Charlson Comorbidity Index was 9, higher than the rest of the cohort.
Conclusions:
Cancer care delivery is safe and feasible using an approach focused on careful patient selection, team communication and infection control.
We report our experience with cancer care delivery during the peak of COVID-19 pandemic in New York City.
Material and methods:
Retrospective analysis of the patients treated from the 1st of March, 2020 to the 8th of May, 2020.
Results:
Team huddles, infection screening and patient selection strategies were implemented. 170 patients were treated in 576 visits. Six developed severe COVID-19 requiring hospitalization, two died. Their median Charlson Comorbidity Index was 9, higher than the rest of the cohort.
Conclusions:
Cancer care delivery is safe and feasible using an approach focused on careful patient selection, team communication and infection control.
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.